SWA
Sutton Wealth Advisors’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $8.48K | Buy |
33
+10
| +43% | +$2.57K | ﹤0.01% | 506 |
|
2023
Q2 | $6.55K | Sell |
23
-3
| -12% | -$855 | ﹤0.01% | 524 |
|
2023
Q1 | $7.23K | Sell |
26
-840
| -97% | -$234K | ﹤0.01% | 476 |
|
2022
Q4 | $240K | Buy |
866
+6
| +0.7% | +$1.66K | 0.09% | 152 |
|
2022
Q3 | $230K | Sell |
860
-13
| -1% | -$3.47K | 0.09% | 153 |
|
2022
Q2 | $178K | Sell |
873
-26
| -3% | -$5.3K | 0.07% | 178 |
|
2022
Q1 | $189K | Buy |
899
+13
| +1% | +$2.74K | 0.07% | 187 |
|
2021
Q4 | $213K | Sell |
886
-5
| -0.6% | -$1.2K | 0.07% | 172 |
|
2021
Q3 | $252K | Sell |
891
-2
| -0.2% | -$566 | 0.09% | 150 |
|
2021
Q2 | $309K | Buy |
893
+3
| +0.3% | +$1.04K | 0.11% | 127 |
|
2021
Q1 | $249K | Buy |
890
+4
| +0.5% | +$1.12K | 0.1% | 144 |
|
2020
Q4 | $217K | Buy |
886
+3
| +0.3% | +$735 | 0.09% | 149 |
|
2020
Q3 | $250K | Sell |
883
-1
| -0.1% | -$284 | 0.12% | 125 |
|
2020
Q2 | $237K | Buy |
884
+3
| +0.3% | +$803 | 0.12% | 124 |
|
2020
Q1 | $279K | Buy |
881
+3
| +0.3% | +$949 | 0.18% | 97 |
|
2019
Q4 | $261K | Hold |
878
| – | – | 0.13% | 125 |
|
2019
Q3 | $204K | Hold |
878
| – | – | 0.11% | 144 |
|
2019
Q2 | $205K | Sell |
878
-3
| -0.3% | -$702 | 0.12% | 139 |
|
2019
Q1 | $208K | Buy |
881
+4
| +0.5% | +$946 | 0.12% | 135 |
|
2018
Q4 | $264K | Hold |
877
| – | – | 0.17% | 100 |
|
2018
Q3 | $310K | Hold |
877
| – | – | 0.2% | 88 |
|
2018
Q2 | $255K | Hold |
877
| – | – | 0.18% | 97 |
|
2018
Q1 | $240K | Hold |
877
| – | – | 0.17% | 104 |
|
2017
Q4 | $279K | Hold |
877
| – | – | 0.2% | 84 |
|
2017
Q3 | $275K | Hold |
877
| – | – | 0.21% | 82 |
|
2017
Q2 | $238K | Buy |
877
+5
| +0.6% | +$1.36K | 0.19% | 90 |
|
2017
Q1 | $238K | Sell |
872
-5
| -0.6% | -$1.37K | 0.2% | 82 |
|
2016
Q4 | $249K | Buy |
877
+3
| +0.3% | +$851 | 0.22% | 77 |
|
2016
Q3 | $274K | Buy |
874
+5
| +0.6% | +$1.57K | 0.25% | 69 |
|
2016
Q2 | $210K | Buy |
869
+3
| +0.3% | +$725 | 0.2% | 87 |
|
2016
Q1 | $225K | Buy |
+866
| New | +$225K | 0.21% | 79 |
|